中文 | English
Return
Total: 95 , 1/10
Show Home Prev Next End page: GO
Author:( Xiaolong YU)

1.Clinical application of anti-carbamylated protein antibody

Xiaolong GUAN ; Wei YU

Journal of Medical Postgraduates 2016;29(4):421-426

2.Expression and significance of MMP-2 and VEGF in retinal neovascularization

Yu, DI ; Xiaolong CHEN

Chinese Ophthalmic Research 2009;27(12):1089-1093

3.Progress on application of radiomics in precise treatment of non-small cell lung cancer

Tianying JIA ; Wen YU ; Xiaolong FU

Chinese Journal of Radiological Medicine and Protection 2016;36(12):947-950

4.Research Progress in Cell Apoptosis Induced by Shikonin and Signal Pathway of Apoptosis

Yu XIE ; Xiaolong HOU ; Chunlian WU

Chinese Journal of Information on Traditional Chinese Medicine 2017;24(3):125-129

5.Research advances in preservation of ovarian function during radiotherapy for cervical carcinoma

Xiaojuan LYU ; Xiaolong CHENG ; Hua YU

Chinese Journal of Radiation Oncology 2016;25(6):661-664

6.Intra-articular injection of synovial mesenchymal stem cells to treat articular cartilage injury

Xiaolong YUAN ; Shengrong BI ; Fangyuan YU

Chinese Journal of Tissue Engineering Research 2015;(36):5892-5897

7.Cysteine-rich 61 siRNA reduces retinal neovascularization of mice

Yu DI ; Yiou ZHANG ; Xiaolong CHEN

Chinese Journal of Ocular Fundus Diseases 2015;31(1):72-76

8.Expression of MMP-9 in Mice with Oxygen-induced Retinal Neovascularization

Yu DI ; Yang YANG ; Xiaolong CHEN

Journal of China Medical University 2016;45(5):409-413

9.The effect of calorie restriction at early age on their islet β cell mass in adulthood of rats

Xiaolong ZHAO ; Yu HU ; Xiaoye HE

Chinese Journal of Geriatrics 2012;31(10):895-898

10.Effect of caloric restriction at early age of rats on their isletβcell function in adulthood

Xiaoyi HE ; Yu HU ; Xiaolong ZHAO

Chinese Journal of Endocrinology and Metabolism 2008;24(3):318-319

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 95 , 1/10 Show Home Prev Next End page: GO